Potassium 2-(1-hydroxypentyl)-benzoate inhibits ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathways

Expression of P-selectin (CD62P) on platelets after thrombin and ADP in hypotrophic and healthy, full-term newborns

(2013) Alicja Wasiluk et al.   Journal of Maternal-Fetal & Neonatal Medicine

Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation

(2012) M Endale et al.   BRITISH JOURNAL OF PHARMACOLOGY

Extracellular Ca2+ modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation

(2011) Sarah Jones et al.   BRITISH JOURNAL OF HAEMATOLOGY

Role of Platelets and Antiplatelet Therapy in Cardiovascular Disease

(2011) Masafumi Ueno et al.   Journal of Atherosclerosis and Thrombosis

Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data

(2011) Gaurav Sharma et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

The evolution of antiplatelet therapy in cardiovascular disease

(2011) Omair Yousuf et al.   Nature Reviews Cardiology

Platelet dysfunction in vascular pathologies and how can it be treated

(2011) Nicoleta Alexandru et al.   THROMBOSIS RESEARCH

Platelet receptor signaling in thrombus formation

(2010) David Stegner et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation

(2008) J. E. Purvis et al.   BLOOD